MeSH D058365 - invasive candidiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002177:Candidiasis
D000072742:Invasive fungal infections
0 Companies
0 Drugs
Success rate
D058387:Candidemia
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Mundipharma | Rezafungin | Rezzayo | 2032-03-02 | 2023-03-22 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
83%5/6
Phase 3
45%5/11
Approved: 0Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use